Dynegy Aktie
WKN DE: A1J5JU / ISIN: US26817R1086
|
28.07.2025 22:43:45
|
Dyne Therapeutics, Inc. Q2 Loss Increases, Misses Estimates
(RTTNews) - Dyne Therapeutics, Inc. (DYN) announced Loss for its second quarter that increased from last year and missed the Street estimates.
The company's earnings totaled -$110.86 million, or -$0.97 per share. This compares with -$65.10 million, or -$0.70 per share, last year.
Analysts on average had expected the company to earn -$0.93 per share. Analysts' estimates typically exclude special items.
Dyne Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$110.86 Mln. vs. -$65.10 Mln. last year. -EPS: -$0.97 vs. -$0.70 last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Dynegy Incmehr Nachrichten
| Keine Nachrichten verfügbar. |